1.Plasma-activated solutions alleviate DSS-induced colitis in mice and promote colonic epithelial cell repair through the eNOS pathway
Xueni WANG ; Kaijie REN ; Yuyi MA ; Tianhao MIN ; Xiaoyuan DENG ; Yuanchang PENG ; Yuanyuan LIU ; Wei WANG ; Tuanhe SUN ; Chengxue DANG ; Hao ZHANG
Journal of Xi'an Jiaotong University(Medical Sciences) 2025;46(1):28-34
Objective To explore the role and potential mechanisms of plasma-activated solution(PAS)in alleviating dextran sulfate sodium salt(DSS)-induced ulcerative colitis.Methods We constructed a DSS-induced ulcerative colitis mouse model and evaluated the effect of PAS in vivo by observing mouse weight,calculating disease activity indexes,detecting inflammatory factors and oxidative stress indicators through ELISA.We also evaluated the effect of PAS on colon cell proliferation and migration ability through clone formation experiments,scratch experiments,and used Western blotting to determine the expression levels of proliferation-related proteins.Results PAS significantly reversed DSS-induced weight loss and increased disease activity indexes in mice(P<0.05).The serum inflammatory cytokine levels(TNF-α,IL-6 and IL-1β)in PAS group were significantly reduced compared to those in DSS group(P<0.05).PAS treatment could improve the imbalance of colonic redox homeostasis including changes of malondialdehyde,catalase and superoxide dismutase caused by DSS(P<0.05).After the use of endothelial nitric oxide synthase inhibitors,changes in various indicators caused by in vivo PAS disappeared(P<0.001).The clone formation ability of colon cells was stronger in the group treated with PAS,and the expression of proliferation-related proteins increased.Cell scratch experiments suggested that intervention with PAS could reverse the decrease in cell migration ability caused by lipopolysaccharide(P<0.001).After the application of endothelial nitric oxide synthase inhibitors,the pro-proliferative and migratory effects of PAS disappeared(P<0.05).Conclusion PAS alleviate DSS-induced colitis in mice and promote colonic epithelial cell repair through the eNOS pathway.
2.Plasma-activated solutions promote tumor cells'anoikis and inhibit tumor peritoneal metastasis
Tuanhe SUN ; Yuyi MA ; Tianhao MIN ; Kaijie REN ; Xiaoyuan DENG ; Xueni WANG ; Yuanchang PENG ; Yuanyuan LIU ; Chengxue DANG ; Hao ZHANG ; Wei WANG
Journal of Xi'an Jiaotong University(Medical Sciences) 2025;46(1):35-42
Objective To explore the application of plasma-activated solution(PAS)in the treatment of peritoneal metastasis in mice.Methods A mice model of peritoneal tumor transplantation was established,and PAS was prepared for intervention in the mice.The growth of the peritoneally transplanted tumor was assessed using in vivo imaging technology,while the apoptosis level was evaluated through flow cytometry,immunofluorescence,and Western blotting.Results At the in vitro level,there was no significant impact on tumor cell apoptosis level under adherent conditions observed when utilizing PAS(P>0.05).Under non-adherent condition,PAS significantly augmented tumor cell apoptosis level(P<0.05),substantially increased the proportion of deceased cells(P<0.05),and markedly elevated intracellular total and mitochondrial reactive oxygen species levels(P<0.05).In vivo level,using PAS following peritoneal transplanted tumor formation exhibited no noteworthy influence on peritoneal transplanted tumor growth(P>0.05),while immediate utilization of PAS during model conducting effectively reduced abdominal tumor spread(P<0.05).Conclusion PAS inhibits tumor peritoneal dissemination in mice by promoting tumor cell anoikis.
3.Plasma-activated solutions alleviate DSS-induced colitis in mice and promote colonic epithelial cell repair through the eNOS pathway
Xueni WANG ; Kaijie REN ; Yuyi MA ; Tianhao MIN ; Xiaoyuan DENG ; Yuanchang PENG ; Yuanyuan LIU ; Wei WANG ; Tuanhe SUN ; Chengxue DANG ; Hao ZHANG
Journal of Xi'an Jiaotong University(Medical Sciences) 2025;46(1):28-34
Objective To explore the role and potential mechanisms of plasma-activated solution(PAS)in alleviating dextran sulfate sodium salt(DSS)-induced ulcerative colitis.Methods We constructed a DSS-induced ulcerative colitis mouse model and evaluated the effect of PAS in vivo by observing mouse weight,calculating disease activity indexes,detecting inflammatory factors and oxidative stress indicators through ELISA.We also evaluated the effect of PAS on colon cell proliferation and migration ability through clone formation experiments,scratch experiments,and used Western blotting to determine the expression levels of proliferation-related proteins.Results PAS significantly reversed DSS-induced weight loss and increased disease activity indexes in mice(P<0.05).The serum inflammatory cytokine levels(TNF-α,IL-6 and IL-1β)in PAS group were significantly reduced compared to those in DSS group(P<0.05).PAS treatment could improve the imbalance of colonic redox homeostasis including changes of malondialdehyde,catalase and superoxide dismutase caused by DSS(P<0.05).After the use of endothelial nitric oxide synthase inhibitors,changes in various indicators caused by in vivo PAS disappeared(P<0.001).The clone formation ability of colon cells was stronger in the group treated with PAS,and the expression of proliferation-related proteins increased.Cell scratch experiments suggested that intervention with PAS could reverse the decrease in cell migration ability caused by lipopolysaccharide(P<0.001).After the application of endothelial nitric oxide synthase inhibitors,the pro-proliferative and migratory effects of PAS disappeared(P<0.05).Conclusion PAS alleviate DSS-induced colitis in mice and promote colonic epithelial cell repair through the eNOS pathway.
4.Plasma-activated solutions promote tumor cells'anoikis and inhibit tumor peritoneal metastasis
Tuanhe SUN ; Yuyi MA ; Tianhao MIN ; Kaijie REN ; Xiaoyuan DENG ; Xueni WANG ; Yuanchang PENG ; Yuanyuan LIU ; Chengxue DANG ; Hao ZHANG ; Wei WANG
Journal of Xi'an Jiaotong University(Medical Sciences) 2025;46(1):35-42
Objective To explore the application of plasma-activated solution(PAS)in the treatment of peritoneal metastasis in mice.Methods A mice model of peritoneal tumor transplantation was established,and PAS was prepared for intervention in the mice.The growth of the peritoneally transplanted tumor was assessed using in vivo imaging technology,while the apoptosis level was evaluated through flow cytometry,immunofluorescence,and Western blotting.Results At the in vitro level,there was no significant impact on tumor cell apoptosis level under adherent conditions observed when utilizing PAS(P>0.05).Under non-adherent condition,PAS significantly augmented tumor cell apoptosis level(P<0.05),substantially increased the proportion of deceased cells(P<0.05),and markedly elevated intracellular total and mitochondrial reactive oxygen species levels(P<0.05).In vivo level,using PAS following peritoneal transplanted tumor formation exhibited no noteworthy influence on peritoneal transplanted tumor growth(P>0.05),while immediate utilization of PAS during model conducting effectively reduced abdominal tumor spread(P<0.05).Conclusion PAS inhibits tumor peritoneal dissemination in mice by promoting tumor cell anoikis.
5.Identification of key genes and pathways associated with esophageal adenocarcinoma development based on GEO database and bioinformatics
Zhangjian ZHOU ; Xin XIE ; Xuan WANG ; Hao ZHANG ; Chengxue DANG
Journal of Xi'an Jiaotong University(Medical Sciences) 2021;42(3):419-426
【Objective】 To investigate the potential genes and pathways associated with esophageal adenocarcinoma through microarray expression profiling data analysis and bioinformatics approaches. 【Methods】 The mRNA expression microarray data related to esophageal adenocarcinoma development were screened out with GEO database, and the biological processes, signaling pathways and network of these genes were statistically analyzed using "R" software. 【Results】 The GSE26886 was obtained from GEO database. A total of 1383 differentially expressed genes were associated with carcinogenesis of esophageal adenocarcinoma, including 607 up-regulated and 776 down-regulated genes. These genes were involved in metabolism, stimulate responses, cell adhesion, cell regeneration and immune biological processes. Eight significantly enriched pathways were identified by pathway analysis. 【Conclusion】 The bioinformatic method can analyze the gene chip data effectively. Multiple genes and signaling pathways are involved in the carcinogenesis of esophageal adenocarcinoma, which provides a new idea or approach for exploring biomarkers of early screening and therapeutic targets.
6.Application of humanities curriculum by narrative-based instruction in training of graduate students in oncology
Dawei YUAN ; Tuanhe SUN ; Kun ZHU ; Chengxue DANG ; Yong ZHANG
Chinese Journal of Medical Education Research 2019;18(1):13-16
In recent years,the application of humanities curricula has gained increasing attention gradually in Chinese medical education.For graduate students in oncology who have just been exposed to the actual clinical work,it is extremely important to develop the comprehensive abilities of physician-patient communication,humanistic care and self psychological dredging.Since 2012,we have conducted humanities curriculum by narrative-based instruction for the clinical intern graduate students in oncology at the department of surgical oncology in the First Affiliated Hospital of Xi'an Jiaotong University,and a good teaching result has been gained.This kind of humanities curricula based on open discussion could be an effective way to improve physician-patient communication ability and reduce the clinical psychology pressure for the graduate students in oncology.
7.Screening of cell cycle-related genes regulated by KIAA0101 in gastric cancer.
Zhi WANG ; Chengxue DANG ; Rong YAN ; Hao ZHANG ; Dawei YUAN ; Kang LI
Journal of Southern Medical University 2018;38(10):1151-1158
OBJECTIVETo screen the genes related to cell cycle under regulation by KIAA0101 in gastric cancer.
METHODSRT-PCR was used to detect the expression level of KIAA0101 gene in gastric cancer tissue and paired adjacent tissues. GO function enrichment analysis and KEGG pathway enrichment analysis were carried out using DAVID database. KEGG was used to map the pathways and the corresponding genes were analyzed. The list of genes associated with the KIAA0101 expression pattern was imported into TCGA cBioPortal to analyze the relationship between the interacting genes and generate a genetic topology map. The candidate genes were screened by RT-PCR.
RESULTSThe expression level of KIAA0101 mRNA was significantly higher in cancer tissues than in paired adjacent tissues (1.104 ± 0.379 0.421 ± 0.172; =0.0179). The system screened genes related with KIAA0101 from 478 tissues by pooled analysis of the expression intensity of all the gene probes. GO function analysis showed that the differential genes were mainly enriched in protein phosphorylation, RNA processing, cell cycle, DNA metabolism, protein transport, acetylation, apoptosis, proteolysis, and redox. The changes in the expression level of KIAA0101 mainly affect the gastric cancer-related pathways including cell cycle, spliceosome, DNA replication, and p53 signal transduction pathway. KEGG pathway maps and gene topology maps showed that the genes related to KIAA0101 (such as BUB1B, MAD2L1, CDC45, CDK1, CCNE1 and CCNB2) were also related to cell cycle. RT-PCR results confirmed significant increments of the expression levels of BUB1B, MAD2L, CDK1, CCNE1, and CCNB2 mRNA in gastric cancer tissues as compared with the paired adjacent gastric tissues ( < 0.05), but CDC45 mRNA did not show significant differential expression in gastric cancer tissues ( > 0.05).
CONCLUSIONSKIAA0101 may affect cell cycle by regulating the expression of BUB1B, MAD2L1, CDK1, CCNE1 and CCNB2, and this finding may provide evidence for understanding how KIAA0101 affects cell cycle and for screening of tumor markers and selection of drug targets.
8.Primary pancreatic neuroendocrine neoplasms:a clinicopathological analysis of 60 cases
Yanxia SUI ; Chengxue DANG ; Yong ZHANG ; Yongchun SONG ; Dongmei DIAO ; Xiaozhi ZHANG ; Suxia HAN ; Ying GAO ; Dongli ZHAO
Chinese Journal of Clinical and Experimental Pathology 2015;(8):873-876
Purpose To study the clinicopathological characteristics of primary pancreatic neuroendocrine neoplasms. Method 60 cases of resected pancreatic neuroendocrine neoplasms according to the WHO (2010) classification of the digestive system of neuroen-docrine tumor to evaluate morphological standard, and combining with the literature to discuss the clinicopathological characteristics. Results Among the 60 cases, 23 cases were male patients, the rest were females, with male and female ratio of 1 ∶ 1. 61. The age of the patients were ranged from 19 to 69 years, with mean age of 49. 38 ± 11. 60 years. Tumor maximum diameter ranged from 0. 5 to 16 cm, and the mean diameter was 3. 29 ± 3. 53 cm. 30 cases located in the pancreatic head, 27 cases in the body and end of the pancre-as and 3 cases in the neck. Pathological examination showed the G1 (24 cases), G2 (25 cases), G3 (9 cases), and mixed adenon-euroendocrine carcinoma ( MANEC) in 2 cases. Immunohistochemical staining showed that NSE, CgA, Syn, and CD56 were diffusely positive expression. 45 patients were followed up for 4~80 months, 7 cases died, of which 1 case was G2, 4 cases were G3, and 2 ca-ses were MANEC. Conclusion Primary pancreatic neuroendocrine neoplasms is a relatively rare pancreatic malignant tumor, and the diagnosis is based primarily on histologic features and immunohistochemical examination. Accurate pathological assessment has impor-tant value to guide clinical treatment and prognosis.
9.Small-cell neuroendocrine carcinoma of the stomach: a clinical and prognostic analysis of 21 cases.
Dawei YUAN ; Rong YAN ; Kang LI ; Kun ZHU ; Yong JIA ; Chengxue DANG ; Email: DANGCHENGXUE@MAIL.XJTU.EDU.CN.
Chinese Journal of Oncology 2015;37(3):227-230
OBJECTIVETo investigate and improve the diagnosis and management of small-cell neuroendocrine carcinoma of the stomach (SCNECS).
METHODSThe clinicopathological information and survival data of 21 cases of SCNECS treated in our hospital from January 2003 to December 2012 were analyzed retrospectively.
RESULTSThe median survival time of the 21 cases was (12.1±1.6) months. The 1-year overall survival rate of the patients was 33.3%. Univariate analysis showed that the risk factors of survival were tumor size, lymph node status, tumor stage, treatment and radical operation or not (P<0.05 for all). Multivariate analysis indicated that independent risk factors were tumor size ≥4.6 cm, lymph node metastasis and tumor stage III/IV (P<0.05 for all). Radical operation and comprehensive treatment (surgery + postoperative chemotherapy) were independent protective factors (all P<0.05).
CONCLUSIONSSCNECS is a rare malignant tumor with early metastasis and poor prognosis. Tumor size, stage, lymph node status, and treatment have potential impact on the prognosis. Comprehensive treatment based on radical operation may improve the survival of SCNECS patients.
Carcinoma, Neuroendocrine ; diagnosis ; Carcinoma, Small Cell ; diagnosis ; Humans ; Lymph Node Excision ; Lymphatic Metastasis ; Prognosis ; Retrospective Studies ; Stomach ; Stomach Neoplasms ; diagnosis ; Survival Rate
10.Small-cell neuroendocrine carcinoma of the stomach:a clinical and prognostic analysis of 21 cases
Dawei YUAN ; Rong YAN ; Kang LI ; Kun ZHU ; Yong JIA ; Chengxue DANG
Chinese Journal of Oncology 2015;(3):227-230
Objective To investigate and improve the diagnosis and management of small-cell neuroendocrine carcinoma of the stomach (SCNECS).Methods The clinicopathological information and survival data of 21 cases of SCNECS treated in our hospital from January 2003 to December 2012 were analyzed retrospectively.Results The median survival time of the 21 cases was (12.1 ±1.6) months.The 1-year overall survival rate of the patients was 33.3%.Univariate analysis showed that the risk factors of survival were tumor size, lymph node status, tumor stage, treatment and radical operation or not (P<0.05 for all).Multivariate analysis indicated that independent risk factors were tumor size≥4.6 cm, lymph node metastasis and tumor stage Ⅲ/Ⅳ ( P <0.05 for all).Radical operation and comprehensive treatment ( surgery +postoperative chemotherapy) were independent protective factors ( all P<0.05) .Conclusions SCNECS is a rare malignant tumor with early metastasis and poor prognosis.Tumor size, stage, lymph node status, and treatment have potential impact on the prognosis.Comprehensive treatment based on radical operation may improve the survival of SCNECS patients.

Result Analysis
Print
Save
E-mail